Concepedia

Roland Feifel

RF

34

Publications

1.7K

Citations

25

H-Index

1988

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Goethe University Frankfurt

Genomics Institute of the Novartis Research Foundation

Karlsruhe Institute of Technology

Roland Feifel is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1988–2023

34

Publications

34

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 144 citations · Full text

, , +5

ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α

Gerald Künstle, Marcel Leist, Stefan Uhlig et al. · Immunology Letters · 1997 · 136 citations

, , +16

p-fluoro-hexahydro-sila-difenidol: The first M2β-selective muscarinic antagonist

Günter Lambrecht, Roland Feifel, Bernhard Forth et al. · European Journal of Pharmacology · 1988 · 129 citations

, , +6

Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes

Günter Lambrecht, Roland Feifel, Monika Wagner-Röder et al. · European Journal of Pharmacology · 1989 · 105 citations · Full text

, , +8

The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice

Volha Ninichuk, Alexander G. Khandoga, Stephan Segerer et al. · American Journal Of Pathology · 2007 · 92 citations · Full text

, , +14

Rows per page

1–5 of 34